The CDC's National Center of Immunization and Respiratory Diseases (NCIRD) developed and maintains HL7 Table 0292, Vaccine Administered (CVX). The link below is the most up to date value set for this table.
It includes both active and inactive vaccines available in the US. CVX codes for inactive vaccines allow transmission of historical immunization records.
When a MVX (manufacturer) code is paired with a CVX (vaccine administered) code, the specific trade named vaccine may be indicated.
CVX Code mapped to product name:
The Army Medical Department designed MEDPROS to provide for the data entry and reporting/tracking
of Medical and Dental Readiness information of Soldiers, Units, and Task Forces.
The primary users of the MEDPROS online applications are the Soldier Readiness Processing
(SRP) locations, Medical Treatment Facilities, National Guard State and Army Reserve
RRC Surgeon's Offices, and unit Commanders at all levels needing to monitor the
Medical Readiness status of their subordinate units and Soldiers. MEDPROS also provides
every Soldier with AKO alerts as to their Individual Medical Readiness status thereby
eliminating their need to obtain access to the online systems.
As an important part of the Medical Operational Data System (MODS), MEDPROS contains
the following 4 key modules:
MRRS is the Navy,
US Marine Corps and US Coast Guard’s Tool for viewing Force Medical Readiness and
immunization tracking. MRRS is a web-based, real-time application with a central
aggregating database, links with existing authoritative data systems including NSIPS
and MCTFS for personnel tracking. MRRS gives headquarters staffs and leadership
a real-time view of Force Medical Readiness and immunization status.
As a module of the USAF Aeromedical
Services Information Management System (ASIMS), AFCITA client provides the
Air Force a data management portal to all of its fixed facilities to track immunization
data for all their personnel. ASIMS Web provides the Air Force the capability to
track immunization data through a web portal for all their personnel both in fixed
or deployed facilities.
Brachman PS, Friedlander AM, Grabenstein JD. Anthrax. In: Plotkin SA, Orenstein WA, Vaccines, 4th ed. Philadelphia: W. B. Saunders, 2003.
Brachman PS, Gold H, Plotkin SA, Fekety FR, Werrin M, Ingraham NR. Field evaluation of a human anthrax vaccine. American Journal of Public Health 1962;52:432-45. http://www.anthrax.mil/documents/338field_eval.pdf
Advisory Committee on Immunization Practices. Use of anthrax vaccine in the United States. MMWR-Morbidity & Mortality Weekly Report 2000;49(RR-15):1-20. http://www.cdc.gov/mmwr/PDF/rr/rr4915.pdf
Food & Drug Administration. Biological products; Bacterial vaccines and toxoids; Implementation of efficacy review. Federal Register 1985;50:51002-117. http://www.anthrax.mil/documents/338field_eval.pdf
Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, Bryne WR, Pavlin JA, Christopher GW, Eitzen EM Jr. Clinical recognition and management of patients exposed to biological warfare agents. Journal of the American Medical Association 1997;278(Aug 6):399-411. http://jama.ama-assn.org/cgi/content/short/278/5/399
Hambleton P, Carman JA, Melling J. Anthrax: The disease in relation to vaccines. Vaccine 1984;2:125-32.
Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Gerberding J, Hauer J, Hughes J, McDade J, Osterholm MT, , Parker G, Perl TM, Russell PK, Tonat K, Working Group on Civilian Biodefense. Anthrax as a biological weapon, 2002: Updated Recommendations for Management. Journal of the American Medical Association 2002;287:2236- 52. http://jama.ama-assn.org/cgi/content/short/287/17/2236
Ivins BE, Fellows PF, Pitt MLM, Estep JE, Welkos SL, Worsham PL, Friedlander AM. Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys. Salisbury Medical Bulletin 1996;87(Suppl): 125-6.
Ivins BE, Pitt MLM, Fellows PF, Farchaus JW, Benner GE, Waag DM, Little SF, Anderson GW Jr., Gibbs PH, Friedlander AM. Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques. Vaccine 1998;16:1141-8.
Pitt MLM, Ivins BE, Estep JE, et al. Comparison of the efficacy of purified protective antigen and MDPH to protect non-human primates from inhalation anthrax. Salisbury Medical Bulletin. 1996;87:130.
Sidell FR, Takafuji ET, Franz DR. Medical Aspects of Chemical & Biological Warfare. Washington, DC: Department of the Army, 1997.
Turnbull PCB. Guidelines for the Surveillance and Control of Anthrax in Humans and Animals, 3rd ed., WHO Report WHO/EMC/ZDI/98.6.
We welcome all healthcare workers to the DoD Immunization University. We are committed
to making this the most fruitful single location to access to a wide range of training
products relating to immunization services.
What is Immunization University?
An informal collection of guidelines and training resources, sponsored by the
Military Vaccine Agency - Vaccine Healthcare Centers Network,
to help staff make every immunization an excellent one. Designed
to enhance the skills of healthcare workers from a variety of professional and paraprofessional
backgrounds, "Immunization University" offers training on vaccine products and immunization
services through distance learning and on-site classes.
The ImzU logo, with its torch as beacon, emphasizes our educational efforts via
Immunization University, “Imz U.” Established in 2005, its motto is “Each Immunization
an Excellent One,” summarizing our obligations as leaders and clinicians in the
United States Armed Forces. The banner reads Scientia * Tutela * Salveo, referring
to our keystones of knowledge, protection, and health.
The core elements of Immunization University are available
Additional tools and courses will be added over time. Please sign up for our ListServ
which will also include updates as they become available. You may also check back
to this page regularly for the latest information on Immunization University.
The MILVAX-VHCN ListServ is a bimonthly electronic newsletter sent to ImzU registered
users. It includes important information about DoD vaccines, immunization policies
and practices, training opportunities, and other vaccine-related information; as
well as the latest ACIP and CDC guidelines and recommendations.
Review archived copies
of these messages.